Once again, Walgreens is trying to sell British Boots pharmacies

2 Min Read

Walgreens Boots Alliance is reportedly once again trying to sell its Boots pharmacies in the UK as CEO Tim Wentworth and his new management team review the company’s operations.

Under Wentworth, who took over as CEO of Walgreens last October, the company is closing underperforming businesses, such as certain VillageMD physician-staffed clinics, and investing in more lucrative opportunities such as specialty pharmacies.

Bloomberg News reported this on Monday that Walgreens has contacted potential buyers of the U.K.-based drugstore chain. Meanwhile, sources within Walgreens have said that Wentworth and the executives he has hired have little interest in running businesses outside the U.S. and are focused entirely on building America’s health care services and pharmacy businesses.

Less than a month ago, Walgreens announced plans to launch Walgreens Specialty Pharmacy, a $24 billion company that will integrate a new pharmacy equipped to handle gene and cell therapies with its existing pharmacy assets, including the major specialty pharmacy and home delivery business AllianceRx . The move will take effect on August 1 when AllianceRx Walgreens Pharmacy becomes Walgreens Specialty Pharmacy.

Wentworth has more than 30 years of experience in the healthcare sector, and before joining Walgreens, he was largely focused on the U.S. healthcare business, including his work as CEO of Evernorth, Cigna’s $100 billion healthcare company, which also includes Express Scripts, the major pharmacy benefits management company. Wentworth was CEO of Express Scripts when the PBM was sold to Cigna for $54 billion.

See also  Poorer English breast cancer survivors face a higher second risk of cancer
Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *